Gunze LimitedTSE: 3002

Consolidated Financial Results for the Second Quarter

· Issued by Gunze Limited
Business Report

Consolidated Financial Statements for the Second Quarter of FY2025 (Ending March 31, 2026)

GUNZE LIMITED

TSE Prime (Code:3002)

Contents
  1. Financial Statements for the Second Quarter of FY2025
  2. Business Summary for the Second Quarter of FY2025
  3. Forecast for FY2025
  1. Financial Statements for the Second Quarter of FY2025 (Ending March 31, 2026)

    Consolidated operating results

    (Million of yen)

    FY2025 2Q

    Bottom Profit Margin

    FY2024 2Q

    Bottom Profit Margin

    Y on Y

    Increase

    (Decrease)

    Change

    (%)

    Net Sales

    65,270

    67,329

    (2,059)

    (3.1)

    Operating profit

    3,186

    4.9%

    3,566

    5.3%

    (379)

    (10.7)

    Ordinary profit

    3,205

    4.9%

    3,667

    5.4%

    (462)

    (12.6)

    Profit attributable to owners of parent

    (658)

    (1.0%)

    2,956

    4.4%

    (3,615)

    -

    Apparel Business Restructuring Expenses (3,498)

(Major Extraordinary Loss)

Consolidated operating results

  • Net sales: Decreased by ¥2,059 million due to the cessation of operations of electronic components at the end of the previous fiscal year and stagnant domestic and international demand for plastic film.

  • Operating and ordinary profit: Operating profit decreased by ¥379 million and ordinary profit decreased by ¥462 million due to increased fixed costs in the Medical and decreased sales volume and increased costs in the Apparel.

  • Net loss attributable to owners of parent: Decreased by ¥3,615 million, primarily due to restructuring costs in the apparel business that were recorded in the first quarter.

  • Full-Year Forecast: The previously announced financial forecast remains unchanged since the results of the current interim consolidated accounting period are generally within the expected range.

Mid-Term Management Plan VISION 2030 Stage 2

To Be “Company of Choice Globally”, Advance Business Foundation.

Reduce costs by utilizing external knowledge

(Build-Up Project)

Business Process

Reform

Business Structure Reform

Apparel Structural Reform

(AX Project)

Efficiency and speed

Improving Corporate Fundamentals

Human capital activation

Rebirth into value-creating business

Corporate Culture Reform

Personnel System Reform

Apparel Structural Reform

FY 2024 to 2027

Operating Profit Improvement Target: ¥3.3 billion

Items

Close domestic production sites

Close domestic

logistics sites

FY2025 FY2026 FY2027

Enhance Gunze's original value while improving cost competitiveness.

Yanase Factory: Closed at

the end of March Tohoku Gunze: Closed at the end of December

Reduce inventory and improve functionality by consolidating logistics hubs and restructuring.

Ayabe: Closed at the

end of December

Fukuchiyama: Closed at the end of December

Voluntary retirement

program

Optimize indirect personnel to transform the business model by

specializing in specific areas.

Voluntary Retirement Program Applicants: 82 applicants. "Next Challenge Program" Support Details:

-Retirement Bonus Payment: An extra added to the standard retirement allowance.

-Reemployment Support Services: In addition to support from public institutions, individuals

Resigned on January 20

Personnel system reform

Develop a talent and organizational culture that can implement management strategies to enhance sustainable corporate value and competitiveness.

The ideal personnel profile

Individuals who understand diversity

Self-reliant individuals

Challenge-driven individuals

Human resource management policy

Fairness

Convincing

Transparency

Seniority-based

⇒ Merit-based

Achieving the optimal balance between individual career development and organizational management

Promote open and honest

communication

Human resources initiatives

Our vision (To-be)

Recruitment

Accepting diverse talent and increasing mid-career hiring to 50%.

Assignment

Implement systems that enable work arrangements that accommodate work-life balance.

Development

Self-directed development: - Categorizing and developing employees

into management, supervisory, and highly specialized roles.

Evaluation

Enhanced transparency: Rewarding evaluations of challenging talents and minimizing seniority-based elements.

Compensation

(Grade/Pay)

Job-based system (management roles): Wage structure is aligned with

job responsibilities or roles.

Strengthen the company's competitiveness by attracting self-reliant and proactive individuals who embrace challenges.

Personnel system reform

Build-Up Project

-Reduce costs by utilizing external knowledge-

Purpose

Cost Reduction

Despite rising labor costs and soaring expenses for raw materials and energy, the company will strive to enhance our competitiveness and profitability.

Corporate

restructuring

-Take a fresh look at work methods.

-Prioritize speed and external insights.

Previously: Cost reduction driven by insights from each internal department.

Current Approach: To leverage external expertise, a dedicated organization will be established at headquarters and made available to all employees.

I-5(2). Initiatives to enhance corporate fundamentals

Build-Up Project

-Reduce costs by utilizing external knowledge-

Conduct a comprehensive review to identify all potential cost reduction areas from the ground up.

This includes general expenses, direct material costs, logistics costs, utility

costs, repair costs, auxiliary material costs, administrative personnel costs,

and manufacturing overhead personnel costs.

Pursuit of overall optimization

Fact- and data-driven approach

Thorough cost reduction initiatives.

Boost each employee's responsiveness and strengthen competitiveness.

I-6. Second Quarter Financial Summary

Key Points of Segment Performance (April 1, 2025 to September 30, 2025)

Decrease in sales and increase in profit

Functional Solutions

Medical

Apparel

Lifestyle Creations

  • Sluggish consumption of plastic films is due to food price hikes and low-price competition in overseas markets.

  • Engineering plastics products for the office automation sector generally performed well, while those for the semiconductor market were impacted by the downturn in market conditions.

  • Sales decreased by approximately ¥1.6 billion due to the cessation of operations of electronic components business.

    Increase in sales and decrease in profit

  • Domestic sales of absorbable medical devices, such as anti-adhesion and bone fixation materials, saw steady expansion. However, sales of purchased items, such as medical lasers, faced challenges due to intensifying competition.

  • Sales in China generally progressed smoothly, focusing on tissue reinforcement materials, but were affected by

    costly medical regulations.

  • In addition to the impact of the weakening yuan on the exchange rate, fixed costs increased due to capital expenditures for business expansion and personnel growth.

    Decrease in sales and profit

  • While retail channels, such as apparel mass retailers, were impacted by unfavorable weather, reduced sales floor space, and consumers' reluctance to purchase clothing, e-commerce channels experienced sales growth, primarily driven by differentiated products, such as ASEDORON and women's underwear.

  • The company faced increased costs, including higher material and labor expenses, due to reduced production

    volumes resulting from inventory reduction efforts as part of its business restructuring.

    Increase in sales and profit

  • The real estate segment performed well, driven by increased visitor traffic due to the renewal of commercial

    facilities.

  • Profitability in the sports club segment improved due to sales recovery at existing stores and reduced unprofitable locations.

Net Sales

Operating Profit

Bottom: Profit Margin

FY2025 N2Q

FY2024 N2Q

YoY

FY2025 N2Q

FY2024 N2Q

YoY

Functional Solutions

23,667

25,635

(7.7%)

(1,967)

3,346

14.2%

3,251

12.7%

2.9%

94

Medical

6,480

6,468

0.2%

12

948

14.6%

1,279

19.8%

(25.8%)

(330)

Apparel

29,785

29,869

(0.3%)

(84)

249

0.8%

417

1.4%

(40.3%)

(168)

Lifestyle Creations

5,838

5,737

1.8%

101

475

8.1%

303

5.3%

56.8%

172

Total

65,270

67,329

(3.1%)

(2,059)

3,186

4.9%

3,566

5.3%

(10.7%)

(379)

Ⅰ-7. FY2025 N2Q Performance by Segment

Consolidated Performance

(millions of yen)

Ⅰ-8. FY2025 N2Q Segment Composition

(Million of yen)

FY2025 2Q

9%

5,838

36%

5%

249

9%

475

23,667

45%

29,785

19%

948

Sales

¥65.2 billion

Operating profit

¥3.1 billion

67%

3,346

Operating Profit

Sales 

10%

6,480

Apparel

Medical

(BM: FY2022 2Q)

Lifestyle Creation Functional Solutions

Lifestyle Creation

Functional Solutions

11%

7,172

4%

4% 198

190

37%

68%

44%

24%

1,078

Sales

¥67.3 billion Operating Profit

¥3.5 billion

24,836

30,082

3,114

Operating profit

Sales

8%

5,631

Apparel Medical

Ⅰ-9. Net Sales & Operating Profit for FY2025 2Q

Net Sales 65,270 YoY (3.1%) (Million of yen)

Operating Profit 3,186 YoY (10.7%)

<Sales by Business Segment>

Profit Margin: %

67,350 65,153 67,329

65,270

Functional

3,566

3,230

5.0

3,186

4.2

5.3

198

3,251

3,346

2,937

3,114

907

1,279

948

1,078

775

417

249

475

190

297

303

2,806

4.9

24,836

5,631

24,251

5,492

25,635

6,468

23,667

6,480

Solutions

36%

Medical 10%

Function Solutions 67%

30,082

7,172

29,373

6,428

29,869

5,737

29,785

5,838

Apparel 45%

Life Creation 9%

Medical

19%

Apparel

5%

Life

Creation

15

FY2022 FY2023 FY2024 FY2025

FY2022 FY2023 FY2024 FY2025 9%

Through the sale of electronic components business,

Functional Solutions sales decreased.

Decrease in profit due to increased fixed costs in the medical and a significant impact from reduced apparel profits during restructuring.

I-10. Quarterly Financial Results

(Million of yen)

1Q

2Q

FY2025

FY2024

Increase/Decrease

FY2025

FY2024

Increase/Decrease

Net sales

32,240

33,382

(1,142)

(3.4)

33,029

33,946

(917)

(2.7)

Functional Solutions

11,515

12,650

(1,135)

(9.0)

12,152

12,984

(832)

(6.4)

Medical

3,145

3,109

35

1.1

3,335

3,358

(22)

(0.7)

Apparel

14,763

14,795

(31)

(0.2)

15,021

15,074

(52)

(0.3)

Life Creation

3,018

3,024

(5)

(0.2)

2,819

2,712

107

3.9

Operating profit

1,806

2,083

(277)

(13.3)

1,380

1,483

(103)

(6.9)

Functional Solutions

1,582

1,665

(83)

(5.0)

1,764

1,585

178

11.2

Medical

540

594

(53)

(8.9)

407

685

(277)

(40.4)

Apparel

363

563

(200)

(35.6)

(113)

(146)

32

-

Life Creation

246

150

96

64.0

228

152

76

50.0

Ordinary profit

1,838

2,272

(434)

(19.1)

1,366

1,394

(28)

(2.0)

Profit attributable to owners of parent

(1,473)

1,600

(3,074)

-

814

1,356

(542)

(40.0)

I-11. Financial Results for FY2025 2Q

(Million of yen)

FY2025 2Q

FY2024

2Q

Change

Total Assets

157,440

159,677

(2,237)

Equity

110,816

119,074

(8,258)

Equity Ratio

70.4%

74.6%

(4.2%)

Interest-bearing debt

15,727

8,960

6,767

BPS

Net Assets per Share (JPY)

3,410.34

3,667.20

(256.86)

III-6. Details of Changes in Assets

Difference from the end of the previous period (Billions of yen)

Cash and Deposits

(1.2)

(0.6)

Accounts

(1.0)

Property, Plant and equipment

Decrease of 2.2

0.4

receivable

Inventories

(0.4)

0.5

0.1

Others

159.6

Others

Investment in securities

157.4

End of FY2024 Total assets

< Current assets (3.2) >

< Fixed assets 1.0 >

End of Sept., 2025 Total assets

Ⅰ-13. Cash Flow

Cash Flow

(Million of yen)

FY 2025

2Q

FY 2024

2Q

Change

  • Breakdown of Operating CF

Operating profit

3,186

Depreciation and amortization

3,553

  • Breakdown of Investment CF

Purchase of Fixed Assets

(7,906)

  • Breakdown of Financial CF

Increase in short-term debt and commercial paper

7,285

Dividend Paid

(6,296)

Operating Activities

6,650

5,651

998

Investing

Activities

(7,997)

(4,254)

(3,742)

FCF

(1,347)

1,397

(2,744)

Financing

Activities

554

571

(17)

Cash and Cash Equivalents

9,380

13,345

(3,965)

I-14. Capital Expenditures and Depreciation Expenses

YoY Change at 2Q

(Million of yen)

Capital Expenditures

Depreciation

FY 2025

FY 2024

Change

FY 2025

FY 2024

Change

Forecast

2Q

Full-Year

Forecast

2Q

Full-Year

Functional Solutions

7,500

5,063

1,784

5,716

3,100

1,434

2,803

297

Medical

3,300

971

2,315

985

800

335

575

225

Apparel

3,500

431

1,961

1,539

1,700

715

1,432

268

Life Creation

1,400

776

842

558

1,600

793

1,516

84

Other

500

146

634

(134)

600

296

539

61

Total

16,200

7,389

7,538

8,662

7,800

3,575

6,867

933

Engineering Plastics: Capacity expansion and new plant

Major investment plan

in FY2025

construction

4,000

20

Medical: Capacity expansion and new plant construction 3,000

Apparel: Overseas production facility relocation due to business restructuring

1,700

21

  1. Business Review for the Second Quarter

    Ⅱ-1. Business Review for the Second Quarter

    F u n c t i o n a l S o l u t i o n s 1

    Position

    Plastic films

    Introduce new environmentally friendly products to the market and promote

    the development of recycling factories.

    Profit increased

    Category

    Shrink film domestic

    Flexible packaging

    Industrial Packaging

    OPP film

    Shrink film overseas

    Main Products

    Hybrid styrene shrink film is made by coextrusion of PET and PS.

    It has both well shrinkage and shrink characteristics.

    Olefin shrink film has a low specific gravity and easy to recycle.

    The products have excellent gas barrier and pinhole resistance for food industry.

    For semiconductor manufacturing , EV batteries, and wallpaper industry etc.

    Excellent anti-fog characteristic for food package.

    Shrink films can be supplied world wide. The company has three production site in USA, China, and Vietnam.

    Topics

    Although the beverage sector has been impacted by declining consumer sentiment and increased final product prices, it has expanded its sales channels, particularly for environmentally conscious products.

    Due to rising prices and sluggish domestic consumption, the company launched products that balance functionality and affordability in the general-purpose market to secure new sales channels.

    The market remains robust, driven primarily by increased demand for generative AI-related products and steady demand for semiconductor tapes used in expanding data centers.

    Focusing on high-value products through production consolidation and

    prioritizing profitability.

    The price offensive of Chinese products impacts all locations.

    US: Mitigating the impact of additional tariffs through cost reduction and price pass-through.

    Vietnam: Rebuilding competitiveness through cost reduction. China: Working to improve profitability through cost reduction and

    22

    Shrink film overseas

    Shrink film domestic

    reviewing the production system.

    OPP

    Industrial

    Flexible

    Ⅱ-1. Business Review for the Second Quarter

    Profit increased

    Position

    F u n c t i o n a l S o l u t i o n s 2

    Engineering plastics

    To drive business growth, we will strive to expand our share of the OA market while strengthening our non-OA categories, such as semiconductors, medical equipment, and energy.

    Category

    Main Products

    Topics

    OA Functional

    products

    Fluorine thin film tubes for fusing belts/rolls. The intermediate transfer belt has the top share in the global market.

    Office multifunction devices and commercial printing

    products continue to grow.

    Non-OA products

    Functional parts used in manufacturing

    processes in the industrial market.

    • Semiconductor products are affected by the market downturn.

    • A new production line begins operation.

    • Seamless belt ■Fluorine thin-walled

      tubing

    • Filter support materials

      • Tear-resistant fluoropolymer tubing

    For OA Non-OA

    Ⅱ-3. Business Review for the Second Quarter

    Position

    Medical

    Medical

    By offering innovative ‘biomaterials × devices’ and steadily expanding sales—especially of absorbable products, we aim to grow into a globally expanding medical device company

    Growth & expansion

    Category

    Bioabsorbable

    reinforcement felt

    Bone fixation devices

    Main products

    Suitable for reinforcing sutures and preventing air leakage during surgery.

    Effective as a scaffold material for tissue regeneration.

    Bioabsorbable bone grafting material with special processing.

    Topics

    Japan: Steady progress, including additional benefits from new product

    launches.

    China: Despite intensifying medical insurance cutbacks at large general hospitals, Focusing on penetration into mid-sized hospitals and regional areas. Impacted by the weak yen.

    Japan: Stable expansion in acquiring cases in oral surgery.

    China: Impacted by purchasing adjustments aimed at reducing high medical costs.

    Artificial dermis

    Absorbable adhesion barrier sheet

    Purchased products

    like medical laser

    Absorbable artificial skin using collagen.

    Absorbable anti-adhesion material consisting of gelatin in film form with an uneven surface.

    Medical devices for cosmetics, plastic

    surgery, wound care and other products.

    Japan: Maintaining current status despite the impact of competitors' new

    product entries.

    Progress is being made in capturing facilities through strengthened sales activities and pricing strategies. However, intense blocking by competitors is intensifying competition. New factory environmental preparations are underway.

    Medical lasers: The hair removal market is showing a recovery trend,

    However, new competition is emerging, including the distribution of used

    and others

    equipment.

    Domestic sales

    Overseas sales

    Business Direction

Ⅱ-4. Business Review for the Second Quarter

A p p a r e l

Restructur ing

Focusing on the value-added category, we are strengthening initiatives such as production and logistics restructuring and improving efficiency in indirect departments to enhance capital efficiency and revitalize the business into a sustainable one

Innerwear
  • While advancing the prioritization of comprehensive brands,

    cost increases since the beginning of the year, resulting in a decline in profits.

  • Focusing on key brands, consolidating brands, and reducing SKUs.

  • Centering on e-commerce, the company is accelerating the shift to D2C.

    ASEDORON

    ASEDORON: Our product line is designed specifically for year-round sweat

    management.

    KIREILABO: Our line of seamless products, which promotes gentleness for healthy skin, is experiencing strong growth.

    Legwear
  • Sales have been sluggish due to deteriorating market conditions, and price adjustments are being implemented

Panty hose: Struggled in Q1 due to cautious buying amid unstable weather and rising prices. Implemented partial price revisions starting in NQ2.

Socks: Withdrew from unprofitable categories, which led to a reduction in sales volume. However, profitability is trending upward.

YG "in·T"

SABRINA

Foot Covers

BODYWILD

KIREILABO

Legwear

KIREILABO

Men's Lady's Leg

Business Direction

Ⅱ-5. Business Review for the Second Quarter

L i fe s t yl e Cre at i o ns

Restructuring

Real Estate Business

- Shopping center business

Strengthen property-specific management focused on investment efficiency, and

improve low-yield assets or shift them to growth areas and new fields

Tsukashin (Amagasaki, Hyogo): In addition to the effects of the renovation, the number of

visitors has significantly increased and steady performance due to efforts to attract customers from nearby.

- Real Estate Leasing Business

Both sales and profits are showing steady growth. Tsukashin shopping center

Sports Club Business

Enhance support for underperforming stores, expand the school business, and develop

differentiated services and new formats aligned with local and store-specific needs

  • Close unprofitable stores while maintaining sales and improving profitability.

  • The school business aims to enhance satisfaction and expand sales through membership fee revisions driven

    by service enhancements.

  • The fitness business is strengthening targeted strategies.

School business

Green Business Capture greening demand in development plans and pursue new business

                                               initiatives for CO2 reduction  

The tree sales business was affected by a decrease in demand for large-scale projects, including those related to last fiscal year's expo. Construction delays caused by intense heat also impacted the business.

26

Ginkgo trees on Midosuji that Gunze donated last year

  1. Outlook for FY2025

Ⅲ-1. FY2025 Forecast

※No Revision of forecast (millions of yen)

Item

FY2025

FY2024

Change

Forecast

Profit ratio(%)

Results

Profit Ratio(%)

Amount

%

Net Sales

140,000

137,117

2,883

2.1

Operating profit

8,500

6.1

7,921

5.8

579

7.3

Operating

profit

8,300

5.9

8,180

6.0

120

1.5

Profit attributable to owners of parent

※

2,800

2.0

6,279

4.6

(3,479)

(55.4%)

※A decrease in profit is planned due to the expected occurrence of special losses related to structural reforms.

Ⅲ-2. FY2025 Forecast by Segment

※No Revision of forecast (millions of yen)

Net Sales

Operating Profit

Bottom: Profit Margin

FY2025

FY2024

Change

FY2025

FY2024

Change

Functional Solutions

50,500

52,204

(3.3%)

(1,704)

8,100

16.0%

7,205

13.8%

12.4%

895

Medical

15,600

12,949

20.5%

2,651

2,500

16.0%

2,430

18.8%

2.9%

70

Apparel

61,400

60,782

1.0%

618

400

0.7%

753

1.2%

(46.9%)

(353)

Lifestyle

Creations

13,200

12,005

10.0%

1,195

1,200

9.1%

988

8.3%

21.5%

212

Total

140,000

137,117

2.1%

2,883

8,500

6.1%

7,921

5.8%

7.3%

579

Ⅲ-3. Distribution of Earnings to Shareholders

Dividend Per Share and Dividend Payout Ratio

(Unit: JPY)

Forecast

450.0

400.0

350.0

250.5%

300.0%

144.5

50.8%

Dividend payout

ratio

102.8%

ordinary dividend

commemorative divident

Special

dividend

48.8%

46.9%

95.1%

82.9%

56.2%

44.7%

0.0%

5.0

45.2%

47.5%

37.5

37.5

147.0

50.5

69.0

37.5

45.0

55.0

57.5

57.5

70.0

73.5

76.5

250.0%

300.0 200.0%

250.0

200.0

150.0

150.0%

100.0%

100.0

50.0

0.0

※ As of April 1, 2025, a stock split will be conducted at a ratio of 2 shares for each ordinary share Prior periods are also stated on a post-stock split basis

2015/3 2016/3 2017/3 2018/3 2019/3 2020/3 2021/3 2022/3 2023/3 2024/3 2025/3 2026/3※

50.0%

0.0%

Earlier from Gunze

All Gunze news releases